Track market-moving stories before they get noisy

Johnson Controls International NYSE: JCI reported stronger fiscal second-quarter results and raised its full-year earnings outlook, citing sustained demand for applied HVAC systems, data center projects and improving execution across the business.

On May 18, 2026, Johnson Controls International PLC (JCI) shares fell 4.0% to a current price of $137.31. This decline is notable within the context of its 52-w

CORK, Ireland, May 22, 2026 /PRNewswire/ -- Johnson Controls International plc (NYSE: JCI), a global leader in thermal management, mission-critical building systems, energy efficiency, and decarbonization, will host its previously announced Going to Gemba Day for investors and sell-side analysts on Monday, June 1, 2026. The event will showcase Johnson Controls' strategy, innovation, and execution through site tours and discussions with management, including Chief Executive Officer Joakim Weidemanis and Chief Financial Officer Marc Vandiepenbeeck.

NEUHAUSEN, Switzerland--(BUSINESS WIRE)--Sensormatic Solutions, the leading global retail solutions portfolio of Johnson Controls (NYSE: JCI), now offers two discreet radio-frequency identification (RFID) tagging alternatives for clothing, apparel and accessory for brands and retailers seeking deep insights without compromising garments' look and feel. Its new RFID Seam Tag and RFID Brand Label—which are now available to retailers worldwide—can be sewn directly into garments without altering fi.

Johnson Controls Announces Quarterly Dividend PR Newswire CORK, Ireland, June 3, 2026

New York, June 08, 2026 (GLOBE NEWSWIRE) -- The Insight Partners, published its latest market intelligence report on the Global Smart Home Market. The study finds the market, valued at US$ 159. 92 billion in 2025, is projected to reach US$ 1,434.

Oncotelic Therapeutics (OTCMKTS:OTLC - Get Free Report) and Lexicon Pharmaceuticals (NASDAQ: LXRX - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, analyst recommendations, institutional ownership, profitability and risk. Profitability This table compares Oncotelic Therapeutics and

Additional analyses from the SCORED and SOTA-P-CARDIA studies provide further evidence of benefits across patient subgroups potentially related to sotagliflozin's mechanism of action Additional analyses from the SCORED and SOTA-P-CARDIA studies provide further evidence of benefits across patient subgroups potentially related to sotagliflozin's mechanism of action

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX - Get Free Report) shares crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $1.39 and traded as high as $1.66. Lexicon Pharmaceuticals shares last traded at $1.51, with a volume of 3,357,632 shares trading hands. Wall Street Analysts Forecast Growth

THE WOODLANDS, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its first quarter 2026 financial results on Thursday, May 7, 2026, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss the financial results and to provide a business update.

SONATA-HCM anticipated to be fully enrolled mid-2026  Resubmission of NDA for ZYNQUISTA ® in type 1 diabetes anticipated mid-2026 with potential for approval this year Clinical development of LX9851 initiated by Novo Nordisk Capital raise, development milestone payments, and recent $100 million loan facility reinforce strong financial position   Conference call and webcast at 8:30 am ET    THE WOODLANDS, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended March 31, 2026, and provided an update on key corporate milestones and accomplishments. “We have been intently focused on progressing our late and early-stage development pipeline in cardiometabolism and we are now well positioned to achieve several pivotal milestones as a result of those efforts,” said Mike Exton, Ph.D.

Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2026 Earnings Call Transcript

THE WOODLANDS, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference, taking place at the Nasdaq World Headquarters in New York City, on May 19, 2026.

Presentations highlight consistent A1c reductions with sotagliflozin in type 1 diabetes and pharmacokinetics of pilavapadin across renal function groups Presentations highlight consistent A1c reductions with sotagliflozin in type 1 diabetes and pharmacokinetics of pilavapadin across renal function groups

EMN tops Q1 earnings estimates despite a sales miss, as pricing actions and Chemical Intermediates tailwinds shape 2026.

On May 01, 2026, Eastman Chemical Co (EMN) shares rose 6.1%, closing at $77.53. The stock has been on a positive trajectory recently, with a 1-week increase of

Explore Eastman Chemical's (EMN) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

KINGSPORT, Tenn.--(BUSINESS WIRE)--The Board of Directors of Eastman Chemical Company (NYSE:EMN) has declared a quarterly cash dividend of $0.84 per share on the company's common stock.

Eastman Chemical CEO Mark Costa discusses the impact of the Middle East conflict on global petrochemical markets and the plastic supply chain on ‘The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theclamancountdown #iran #war #middleeast #conflict #global #petrochemical #plastics #plastic #supplychain #markets #oil #energy #business #economy #ceo #eastmanchemical #markcosta

KINGSPORT, Tenn.--(BUSINESS WIRE)--Eastman announced that its Kingsport, Tennessee, site has achieved ISO 59014 certification through SCS Global Services.

Eastman Chemical: Riding The Cycles To Shareholder Returns

KINGSPORT, Tenn.--(BUSINESS WIRE)--Eastman Board Chair and CEO Mark Costa will address the Deutsche Bank 17th Annual Basic Materials Conference on June 3, 2026, at 9:25 a.m. ET.

Expense ratios, diversification, and long-term returns set these two small-cap value ETFs apart-see how their strategies stack up for investors.

Eastman Chemical Company (EMN) Presents at Deutsche Bank's 17th Annual Basic Materials Conference Transcript

A federal judge ruled on Tuesday that Skechers USA must face a proposed class action accusing the footwear ​and apparel company of illegally blasting consumers with emails ‌that create a false sense of urgency to buy or risk missing out on discounts.